EP3086793
NOTKUN ILDAÐRA KÓLESTERÓLSÚLFATA (OCS) Í MEÐFERÐ VIÐ NÝRNAVANVIRKNI
:
EP Einkaleyfi fallið úr gildi:
23.12.2014:
11.5.2022:
14874617.5
:
5.7.2022:
15.9.2022
:
22.12.2034:
22.12.2024
:
USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR THE TREATMENT OF KIDNEY DYSFUNCTION
23.12.2014
11.5.2022
5.7.2022
15.9.2022
22.12.2024
:
Virginia Commonwealth University:
800 East Leigh Street Suite 3000, Richmond, VA 23298, US
:
The United States Government as Represented by the Department of Veterans Affairs:
810 Vermont Avenue, N.W., Washington, DC 20420, US
:
Durect Corporation:
10260 Bubb Road, Cupertino, CA 95014, US
:
REN, Shunlin:
Richmond, VA 23249, US
:
THEEUWES, Felix:
Los Altos Hills, CA 94022, US
:
BROWN, James E.:
Los Gatos, CA 95032, US
:
LIN, WeiQi:
Emerald Hills, VA 94062, US
:
Tego IP ehf.:
Pósthólf 8129, 128, Reykjavík,
:
201361920617 P:
24.12.2013:
US
:
US2014072128:
23.12.2014
:
A61K 31/575, A61K 31/56, A61P 43/00, A61P 1/16, A61K 31/568, A61K 35/12, A61P 13/12
: 9
: 15.1.2023
: 22.12.2023
: Árnason Faktor ehf.
: 10
: 15.12.2023
: 22.12.2024
: Árnason Faktor ehf.
: 10
: 15.12.2023
: 22.12.2024
: Árnason Faktor ehf.